FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Anti-Gastroesophageal Reflux

PMA: P100049 · Supplement: S002 · Decision Jun 22, 2012
Classifications
1
FEI Numbers
2
Registration Numbers
2

Basic Information

Device Name
Implant, Anti-Gastroesophageal Reflux
Trade Name
LINX REFLUX MANAGEMENT SYSTEM
PMA Number
P100049
Supplement Number
S002
Device Class
FDA Class 3
Product Code
LEI
Generic Name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
June 22, 2012
Date Received
April 23, 2012
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol - OSB
Expedited Review
N

Advisory Committee Statement

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LEI Implant, Anti-Gastroesophageal Reflux